Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIL-SAH
NCT07816159Phase 2Not yet recruiting
- Sponsor
- Rigshospitalet
- Start
- Dec 2026
- Primary completion
- Dec 2029
01
Overview
A Phase 2 trial of lidocaine in Headache, sponsored by Rigshospitalet. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
Headache
Beyond the preview
Go deeper on NCT07816159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07816159.